Market Newsdesk

MCLEAN, Va., Dec. 10, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are backed by underlying collateral consisting of fixed-rate multifamily mortgages with predominantly 10-year terms. The company expects to issue approximately $1.1 billion in K Certificates (K-122 Certificates), which are expected to settle on or about December 17, 2020.

K-
122
Pricing

Details

• Co-Lead Managers and Joint Bookrunners: J.P. Morgan Securities LLC and Barclays Capital Inc.
• Co-Managers: Citigroup Global Markets Inc., Drexel Hamilton, LLC, NatAlliance Securities, LLC and PNC Capital Markets LLC
• Rating Agencies: Fitch Ratings, Inc. and DBRS, Inc.

Related Links

• The K-122 Preliminary Offering Circular Supplement: http://www.freddiemac.com/mbs/data/k122oc.pdf   
• Freddie Mac Multifamily Securitization Overview
• Multifamily Securities Investor Access database of post-securitization data from Investor Reporting Packages
• More information about Class A-M and Class XAM

The K-122 Certificates are backed by corresponding classes issued by the FREMF 2020-K122 Mortgage Trust (K122 Trust) and guaranteed by Freddie Mac. The K122 Trust will also issue certificates consisting of Class X2-A, Class X2-B, Class D and Class R Certificates, which will not be guaranteed by Freddie Mac and will not back any class of K-122 Certificates.

Freddie Mac Multifamily is a leading issuer of agency-guaranteed structured multifamily securities. K-Deals are part of the company’s business strategy to transfer a portion of the risk of losses away from taxpayers and to private investors who purchase the unguaranteed subordinate bonds. K Certificates typically feature a wide range of investor options with stable cash flows and structured credit enhancement.

This announcement is not an offer to sell any Freddie Mac securities. Offers for any given security are made only through applicable offering circulars and related supplements, which incorporate Freddie Mac’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission (SEC) on February 13, 2020; all other reports Freddie Mac filed with the SEC pursuant to Section 13(a) of the Securities Exchange Act of 1934 (Exchange Act) since December 31, 2019, excluding any information “furnished” to the SEC on Form 8-K; and all documents that Freddie Mac files with the SEC pursuant to Sections 13(a), 13(c) or 14 of the Exchange Act, excluding any information “furnished” to the SEC on Form 8-K.

Freddie Mac’s press releases sometimes contain forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, some of which are beyond the company’s control. Management’s expectations for the company’s future necessarily involve a number of assumptions, judgments and estimates, and various factors could cause actual results to differ materially from the expectations expressed in these and other forward-looking statements. These assumptions, judgments, estimates and factors are discussed in the company’s Annual Report on Form 10-K for the year ended December 31, 2019, and its reports on Form 10-Q and Form 8-K, which are available on the Investor Relations page of the company’s Web site at www.FreddieMac.com/investors and the SEC’s website at www.sec.gov.

The company undertakes no obligation to update forward-looking statements it makes to reflect events or circumstances occurring after the date of this press release. The multifamily investors section of the company’s Web site at https://mf.freddiemac.com/investors/ will also be updated, from time to time, with any information on material developments or other events that may be important to investors, and we encourage investors to access this website on a regular basis for such updated information.

The financial and other information contained in the documents that may be accessed on this page speaks only as of the date of those documents. The information could be out of date and no longer accurate. Freddie Mac undertakes no obligation, and disclaims any duty, to update any of the information in those documents.

Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders, and taxpayers. Learn more at FreddieMac.com, Twitter @FreddieMac and Freddie Mac’s blog FreddieMac.com/blog.

MEDIA CONTACT:
Michael Morosi

703
–
918-5851

Michael_Morosi
@FreddieMac.com

INVESTOR CONTACT
S
:
Robert Koontz

571-382-4082

Amanda Nunnink

312
–
407-7510

FRESNO, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) — Mealthy Inc., a kitchen countertop appliance company who is a recently acquired subsidiary of MVP Holdings Inc. is preparing a 2^nd round of crowdfunding on WeFunder.com/Mealthy. WeFunder.com is a crowdfunding platform that has helped raise over $193 million in capital for over 500 startup companies and has over 780,000 investors on its platform.

In August 2019, Mealthy Inc. raised $1.07 million the max allowable at a $30 million dollar valuation in under 90 days in an initial capital raise on the Republic crowdfunding platform. Since that initial raise the crowdfunding regulations have changed and now allow companies such as Mealthy Inc., to raise up to $5 million in a single crowdfunding round every 12 months. Mealthy Inc. is looking to raise up to $3.5 million in a 2^nd round of crowdfunding at a $40 million dollar valuation. In 2020 Mealthy Inc., grew revenues 31% over 2019 and has become profitable for the first time since its launch in 2018. “With improvements in operational costs, an increase in sales and our continued expansion in both US & International markets, along with the launch of several new product lines in 2021 we feel it is the right time to do our next capital raise and that our increased valuation is on the mark. In 2021 Mealthy will be launching 3 new products and looks to release new versions of 2 existing products,” said Mealthy CEO Casey Musick. Mealthy will use funds raised for an increase in digital marketing as well as regional tv advertising in accordance with the launch of the new product lines. Capital raised will also go towards increasing inventory levels of current products as one specific product the Mealthy CrispLid sells out regularly within weeks of inventory hitting the warehouse. Finally, capital will also go towards the launch of new product lines including but not limited to inventory, marketing, R&D, & product packing design and brand development.

“There are over 25 million households in the US with a pressure cooker and we feel that they have been underserved, in regards to new product launches, upgrades, accessories and add-ons that fit within the pressure cooker category. We want to dive deeper into that segment while others are moving to more saturated product lines like blenders, coffee makers etc.” “Mealthy is about people not just product, we want to make home cooking easier not just faster.” “Mealthy has focused on developing a community not just selling products since the day it launched. The Mealthy mobile app, website and social media communities receive over 190,000 visits per month. It’s not just about product with Mealthy, it’s about community, good food, good people and families coming together around the kitchen table, especially during these crazy times. Mealthy is a company that wants to inspire the world to come cook with us, a company that is built on product but powered by people.” – CEO Casey Musick.

About Mea
lthy
Inc.

Mealthy Inc., based in Fresno, Ca. manufactures the #2 selling pressure cooker on the market and in just 3 years has sold over $19M in Mealthy products. The Mealthy Inc., executive team is made up of Fortune 1000 level experienced talent that has helped build the Mealthy brand into what it is today in just 3 short years.

ABOUT MVP HOLDINGS INC.

MVP Holdings Inc. operates in Fresno, Ca. in multiple industries including real estate, consumer goods, consumer services and web-based services. The immediate focus for the Company is to capitalize on the opportunities coming available over the next 18 months in acquisition of real estate holdings in both multi and single family residential as well as looking at multiple acquisitions of various consumer goods and service brands.

Please continue to look for new filings and press releases as we continue to work towards getting agreements signed and getting current with OTC and as we continue to grow the business and announce new launches and partnerships.

MVPT
holds no convertible debt,
will not engage in a reverse split,
and has no plans for dilution.

Forward
–
Looking Information
: The forward-looking information contained in this press release represents the expectations of the company as of the date of this press release and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While the company may elect to, it does not undertake to update this information at any particular time except as required in accordance with applicable securities legislation.

BEIJING, Dec. 10, 2020 (GLOBE NEWSWIRE) — ZW Data Action Technologies Inc.(NASDAQ:CNET) (“ZW Data” or the “Company”), an integrated online advertising, precision marketing and data analytics and other value-added services company, today announced that it has entered into a securities purchase agreement with three institutional investors for a registered direct placement of approximately $7.0 million of shares of common stock of the Company at a price of $1.62 per share. The Company will issue a total of 4,320,988 shares of common stock to the institutional investors. As part of the transaction, the Company will also issue to the investors warrants to purchase up to 1,728,395 shares of common stock at an exercise price of $2.03 per share, which warrants will have a term of three years and not be exercisable for the first six months from the date of issuance.

The net proceeds from this offering are expected to be approximately $6.3 million and will be used for general working capital purposes. If the warrants are exercised in full, the Company will receive additional proceeds of approximately $3.5 million. The completion of the placement is expected to occur on or about December 14, 2020, subject to the satisfaction of customary closing conditions.

FT Global Capital, Inc. acted as the exclusive placement agent in connection with the offering.

The Company’s Common Stock, Warrants and shares of Common Stock underlying the Warrants (the “Securities”) are being offered by in a registered direct offering pursuant to a “shelf” registration statement on Form S-3 (File No. 333-228061) previously filed with the Securities and Exchange Commission (the “SEC”) declared effective by the SEC on August 3, 2020. The Securities may be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. Once filed with the SEC, copies of the prospectus supplement and accompanying prospectus relating to the registered direct offering may be obtained, when available, on the SEC’s website at http://www.sec.gov or by contacting the Company at Room 1106, Xinghuo Keji Plaza, No. 2 Fengfu Road, Fengtai District, Beijing, PRC 100070, or telephone at +86-10-60846616.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities, in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

For further details of this transaction, please see the Form 8-K to be filed with the SEC.

About
ZW Data
Action Technologies
Inc.

Established in 2003 and headquartered in Beijing, China, ZW Data Action Technologies Inc. (the “Company”) offers online advertising, precision marketing, data analytics and other value-added services for enterprise clients. Leveraging its fully integrated services platform, proprietary database, and cutting-edge algorithms, ZW Data Action Technologies delivers customized, result-driven business solutions for small and medium-sized enterprise clients in China. The Company also develops blockchain and artificial intelligence enabled web/mobile applications and software solutions for general public, enterprise clients, and government agencies. More information about the Company can be found at: http://www.zdat.com/.

Safe Harbor

This release contains certain “forward-looking statements” relating to the business of ZW Data Action Technologies Inc., which can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “estimates” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including business uncertainties relating to government regulation of our industry, market demand, reliance on key personnel, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission. These forward-looking statements are based on ZW Data Action Technologies current expectations and beliefs concerning future developments and their potential effects on the Company. There can be no assurance that future developments affecting ZW Data Action Technologies will be those anticipated by ZW Data Action Technologies. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the Company) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by such forward-looking statements. ZW Data Action Technologies undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

For more information please contact:

Sherry Zheng
Weitian Group LLC
Email: [email protected]
Phone: +1 718-213-7386 

OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 10, 2020 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company today announced that the Company’s T-Cell Select reagent kit has been approved for use by the Ministry of Food and Drug Safety, South Korea.

The T-Cell Select reagent kit is an immune cell separation reagent. It is used to automate the preparation of the cells required to run the Company’s T-SPOT.TB test, for diagnosis of TB infection, from patient blood samples.

The T-Cell Select reagent kit streamlines and simplifies the T-SPOT.TB test laboratory protocol. Automation makes implementation of the T-SPOT.TB test easy, reducing hands-on time and saving on labour costs. It also allows for higher throughput and easier integration of the T-SPOT.TB test into the laboratory workflow.

The T-Cell Select reagent kit also has additional advantages. It allows samples to be stored for up to 54 hours at room temperature before use, enabling easy centralisation of sample processing and simplifying sample logistics. This also gives laboratories more flexibility as it allows time for sample batching.

Peter Wrighton-Smith, CEO of Oxford Immunotec, said “The approval of T-Cell Select is a major step forward in simplifying the workflow for our T-SPOT.TB test in South Korea. It will enable adoption of the test in many more labs throughout the country and most importantly will extend the benefits of our test to more patients.”

The T-Cell Select reagent kit has been available throughout Europe under CE mark and is quickly becoming available in more markets around the world.

For additional information, please visit: http://www.oxfordimmunotec.com/international/products-services/t-cell-select/.

About Oxford Immunotec

Oxford Immunotec Global PLC is a global, high-growth diagnostics company. We bring energy and invention to a world in need of diagnostic truth. We are uniquely placed as the only company in the world offering regulated ELISPOT assays for T cell measurement, with approval around the globe. Our leading product, the T-SPOT.TB test, is used for diagnosing infection with Tuberculosis, the world’s largest cause of death from infectious disease. The Company is an experienced manufacturer of IVD tests, operating under a fully audited Quality Management System, ensuring rigorous batch control. The company has manufactured in excess of 20 million clinical T cell tests for TB infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, U.K. and in Marlborough, MA. Additional information can be found at www.oxfordimmunotec.com.

T-SPOT, the Oxford Immunotec logo, and T-Cell Select are trademarks of Oxford Immunotec Limited.

Forward-Looking Statements

This release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this release are forward-looking statements. This includes statements about Oxford Immunotec’s anticipated plans and objectives, future performance and revenues, financial condition, prospects for sales of its products, growth, strategies, expectations and objectives of management. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements contained in this release reflect Oxford Immunotec’s current expectations and are subject to risks and uncertainties. Actual results may differ materially from those projected or implied by forward-looking statements. Other factors that could adversely affect Oxford Immunotec’s business and prospects are described under the “Risk Factors” section in its filings with the Securities and Exchange Commission (“SEC”). Oxford Immunotec’s SEC filings are available for free by visiting the investor section of its website, www.oxfordimmunotec.com, or the SEC’s website, www.sec.gov.

Investors should give careful consideration to these risks and uncertainties. Forward-looking statements contained herein are based on current expectations and assumptions and currently available data and are neither predictions nor guarantees of future events or performance. Investors should not place undue reliance on forward-looking statements contained herein, which speak only as of the date of this release. Oxford Immunotec does not undertake to update or revise any forward-looking statements after they are made, whether as a result of new information, future events, or otherwise, except as required by applicable law.

For Investor Inquiries:

Matt McLaughlin
Chief Financial Officer
Oxford Immunotec
Tel: +1 (508) 573-9953
[email protected]